EARNEST Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-24
| Closed | -$494 | – | 943 |
|
2023
Q3 | $494 | Hold |
24
| – | – | ﹤0.01% | 1118 |
|
2023
Q2 | $1.13K | Hold |
24
| – | – | ﹤0.01% | 1061 |
|
2023
Q1 | $1.01K | Hold |
24
| – | – | ﹤0.01% | 1063 |
|
2022
Q4 | $915 | Hold |
24
| – | – | ﹤0.01% | 1090 |
|
2022
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 1079 |
|
2022
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 1100 |
|
2022
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 1109 |
|
2021
Q4 | $1K | Hold |
24
| – | – | ﹤0.01% | 1126 |
|
2021
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 1130 |
|
2021
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 1134 |
|
2021
Q1 | $2K | Hold |
24
| – | – | ﹤0.01% | 1056 |
|
2020
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 1036 |
|
2020
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 1096 |
|
2020
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 1078 |
|
2020
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 1032 |
|
2019
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 1022 |
|
2019
Q3 | $3K | Hold |
24
| – | – | ﹤0.01% | 923 |
|
2019
Q2 | $4K | Hold |
24
| – | – | ﹤0.01% | 849 |
|
2019
Q1 | $4K | Hold |
24
| – | – | ﹤0.01% | 854 |
|
2018
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 998 |
|
2018
Q3 | $3K | Hold |
24
| – | – | ﹤0.01% | 961 |
|
2018
Q2 | $4K | Buy |
+24
| New | +$4K | ﹤0.01% | 867 |
|